Error processing SSI file
  Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institutes & Offices | Training & Employment | Contact Us
CDC Centers for Disease Control and Prevention Home Page
CDC en Español
Search:  
 What's New | Contact Us
Influenza (Flu) - Protect Yourself and Your Loved Ones
Flu Home > Flu Activity >
Weekly Report: Influenza Summary Update
Week ending February 3, 2001-Week 05

The following information may be quoted:

Synopsis:

During week 5 (January 28 – February 3, 2001)*, 22% of the specimens tested by WHO and NREVSS laboratories were positive for influenza. The proportion of patient visits to sentinel physicians for influenza-like illness was 4% overall in the United States, exceeding baseline levels of 0% to 3%, and was above the baseline in 8 of 9 surveillance regions. The proportion of deaths attributed to pneumonia and influenza was 7.6%. This percentage is below the epidemic threshold for this time of year. Eleven state and territorial health departments reported widespread influenza activity**, 26 reported regional influenza activity, and 13 reported sporadic activity.

U.S. World Health Organization (WHO) and National Respiratory And Enteric Virus Surveillance System(NREVSS)Collaborating Laboratory Reports *:

During week 5, WHO and NREVSS laboratories reported 1,459 specimens tested for influenza viruses, of which 323 (22%) were positive. Sixty-nine (21%) were influenza A (H1N1) viruses, 167 (52%) were unsubtyped influenza A viruses, and 87 (27%) were influenza B viruses. Thirty-seven percent of specimens tested for influenza over the past 3 weeks (weeks 3-5) in the South Atlantic region*** were positive. Between 20% and 30% of specimens tested for influenza over the past 3 weeks in the West South Central, East South Central, East North Central, New England, and West North Central regions were positive. In the remaining 3 regions (Mid-Atlantic, Pacific, and Mountain), the percentage of specimens testing positive for influenza in the past 3 weeks ranged from 12% to 19%.

Since October 1, WHO and NREVSS laboratories have tested a total of 38,030 specimens for influenza viruses, and 4,188 (11%) were positive. Of the 4,188 isolates identified, 2,975 (71%) were influenza type A and 1,213 (29%) were influenza type B. One thousand and seventy-two (36%) of the 2,975 influenza A viruses identified have been subtyped; 1,050 (98%) were A (H1N1) and 22 (2%) were A (H3N2). Influenza A viruses have predominated (range 56% to 86%) in 7 regions (East South Central, New England, Mountain, West North Central, West South Central, South Atlantic, and East North Central), and influenza B viruses have predominated (56%) in the Mid-Atlantic region. The Pacific region has reported approximately equal numbers of influenza A and influenza B isolates this season.

 Influenza Virus Isolated

Antigenic Characterization of Viral Isolates:

CDC has antigenically characterized 247 influenza viruses received from U.S. laboratories since October 1. Of the 121 influenza A (H1N1) isolates that have been characterized, 115 (95%) were similar to A/New Caledonia/20/99, the H1N1 component of the 2000-01 influenza vaccine, and 6 (5%) were similar to A/Bayern/07/95. Although A/Bayern-like viruses are antigenically distinct from the A/New Caledonia-like viruses, the A/New Caledonia/20/99 vaccine strain produces high titers of antibody that cross-react with A/Bayern/07/95-like viruses. Of the 16 influenza A (H3N2) viruses that have been characterized, all were antigenically similar to the vaccine strain A/Panama/2007/99. Of the 110 influenza B viruses characterized, 57 (52%) were similar to the vaccine strain, B/Beijing/184/93, and 53 (48%) were more closely related antigenically to the B/Sichuan/379/99 reference strain. It should be noted that the B/Sichuan virus exhibits cross-reactivity with the vaccine strain.

Pneumonia and Influenza (P&I) Mortality:

During week 5, the percentage of all deaths due to P&I as reported by the vital statistics offices of 122 U.S. cities was 7.6%. This percentage is below the epidemic threshold of 8.7% for week 5.

Pneumonia And Influenza Mortality

View Full Screen

Influenza Morbidity Reports from U.S. Sentinel Physicians*:

During week 5, 4% of patient visits to U.S. sentinel physicians were due to influenza-like illness (ILI). The percentage of ILI was above the baseline levels of 0% to 3% in 8 of the 9 surveillance regions (East South Central, Mid-Atlantic, Mountain, New England, Pacific, South Atlantic, West North Central, and West South Central) and ranged from 4% to 7%.

Bar Chart for Influenza-like Illness

Influenza Activity as Assessed by State and Territorial Epidemiologists**:

Influenza activity was reported as widespread in 11 states (Colorado, Connecticut, Minnesota, Mississippi, North Carolina, Oklahoma, Rhode Island, Tennessee, Utah, Virginia, and Washington) and regional in 26 states (Alabama, Arizona, Arkansas, Georgia, Hawaii, Idaho, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Missouri, Montana, Nebraska, Nevada, New Jersey, New York, North Dakota, Ohio, Oregon, Pennsylvania, South Dakota, Texas, Vermont, and Wyoming). Thirteen states reported sporadic influenza activity.


Usmap for Weekly Influenza Activity


* Reporting is incomplete for this week. Numbers may change as more reports are received.

** Influenza activity is defined as influenza-like illness and/or culture-confirmed influenza.

*** Surveillance Regions: New England (Connecticut, Maine, Massachusetts, New Hampshire, Vermont, Rhode Island); Mid-Atlantic (New Jersey, New York City, Pennsylvania, Upstate New York); East North Central (Illinois, Indiana, Michigan, Ohio, Wisconsin); West North Central (Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota); South Atlantic (Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, Washington, D.C., West Virginia); East South Central (Alabama, Kentucky, Mississippi, Tennessee); West South Central (Arkansas, Louisiana, Oklahoma, Texas); Mountain (Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, Wyoming); Pacific (Alaska, California, Hawaii, Oregon, Washington)

Report prepared: February 8, 2001

 

    Home   |   Policies and Regulations   |  Disclaimer   |  e-Government   |  FOIA   |   Contact Us  
Safer, Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
Tel: 404-639-3311  •  CDC Contact Center: 800-CDC-INFO  •  888-232-6348 (TTY)
FirstGovDHHS Department of Health
and Human Services